FindTrial
Sign In

Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified

DRUG2 trials

Sponsors

Grifols Therapeutics LLC

Conditions

AgammaglobulinemiaCommon Variable ImmunodeficiencyImmunologic Deficiency SyndromeMacular DegenerationSevere Combined ImmunodeficiencyWiskott-Aldrich Syndrome

Phase 2

Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
CompletedNCT00220805
Grifols Therapeutics LLCMacular Degeneration
Start: 2004-01-31End: 2005-05-31Updated: 2016-03-21

Phase 3

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
CompletedNCT00220766
Grifols Therapeutics LLCAgammaglobulinemia, Common Variable Immunodeficiency, Immunologic Deficiency Syndrome +2
Start: 2002-08-31End: 2004-03-31Updated: 2009-09-25